OmniaBio Inc. announces private investor OmniaBio news release, May 31, 2022.
Funding from Ontario Government for OmniaBio. CCRM news release, March 31, 2022.
Invest Ontario Supports New Biomanufacturing Facility in Hamilton Invest Ontario news release, March 31, 2022.
OmniaBio in the News
OmniaBio shares expansion plans with Hamilton investment partners at Collision Conference (with video). Invest in Hamilton website. June 23, 2022.
OmniaBio, Medipost Ink Acquisition and Investment Deal. Contract Pharma, June 7, 2022.
Canada aims to get a slice of the growing global market for cell and gene therapies. Toronto Star, May 18, 2022.
McMaster Innovation Park wants more residential dev. Real Estate News EXchange. May 16, 2022.
What’s A CDMO And Why Do Biotech Startups Need them? Let’s Ask Canada. Crunchbase News, May 5, 2022.
Healthcare Is a Cost. But It’s Also a Business Opportunity. Canadian Business, April 26, 2022.
Gene therapy manufacturing coming to McMaster Innovation Park. The Bay Observer, April 1, 2022.
Ontario antes up $580M for C&G therapy plant in Hamilton. Endpoints News, April 1, 2022.
Ontario invests $40 million to grow global life sciences sector at Hamilton’s McMaster Innovation Park. Toronto Star, April 1, 2022
Ontario invests in $580 million gene and cell therapy facility in Hamilton. CHCH-TV, March 31, 2022.
New gene- and cell-therapy manufacturing facility to launch in Hamilton with $580-million commitment. The Globe and Mail, March 31, 2022.
WATCH: Ontario economic development minister to make announcement in Hamilton at 1:30 p.m. CHCH-TV, March 31, 2022.